Application 218535
- Type
- ANDA
- Sponsor
- ALEMBIC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 12.5MG;200MG;50MG | No | No |
| 002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 18.75MG;200MG;75MG | No | No |
| 003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 25MG;200MG;100MG | No | No |
| 004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 31.25MG;200MG;125MG | No | No |
| 005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 37.5MG;200MG;150MG | No | No |
| 006 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 50MG;200MG;200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218535-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 12.5MG;200MG;50MG | TABLET / ORAL | AB | 2026-02-05 | |
| A218535-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 18.75MG;200MG;75MG | TABLET / ORAL | AB | 2026-02-05 | |
| A218535-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 25MG;200MG;100MG | TABLET / ORAL | AB | 2026-02-05 | |
| A218535-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 31.25MG;200MG;125MG | TABLET / ORAL | AB | 2026-02-05 | |
| A218535-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 37.5MG;200MG;150MG | TABLET / ORAL | AB | 2026-02-05 | |
| A218535-006 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 50MG;200MG;200MG | TABLET / ORAL | AB | 2026-02-05 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218535-001 | AB |
| A218535-002 | AB |
| A218535-003 | AB |
| A218535-004 | AB |
| A218535-005 | AB |
| A218535-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218535-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 12.5MG;200MG;50MG | TABLET / ORAL | AB | 2026-02-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218535-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 18.75MG;200MG;75MG | TABLET / ORAL | AB | 2026-02-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218535-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 25MG;200MG;100MG | TABLET / ORAL | AB | 2026-02-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218535-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 31.25MG;200MG;125MG | TABLET / ORAL | AB | 2026-02-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218535-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 37.5MG;200MG;150MG | TABLET / ORAL | AB | 2026-02-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218535-006 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 50MG;200MG;200MG | TABLET / ORAL | AB | 2026-02-05 | 011fe1cb6892… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 12.5MG;200MG;50MG | TABLET / ORAL | AB | 2026-02-05 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 18.75MG;200MG;75MG | TABLET / ORAL | AB | 2026-02-05 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 25MG;200MG;100MG | TABLET / ORAL | AB | 2026-02-05 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 31.25MG;200MG;125MG | TABLET / ORAL | AB | 2026-02-05 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 37.5MG;200MG;150MG | TABLET / ORAL | AB | 2026-02-05 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-006 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 50MG;200MG;200MG | TABLET / ORAL | AB | 2026-02-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218535-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218535-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218535-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218535-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218535-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218535-006 | AB | 1 | 011fe1cb6892… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-003 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-004 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-005 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218535-006 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| carbidopa, levodopa and entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Alembic Pharmaceuticals Inc. | 9d4e886e-edec-471d-b619-bf4828a6b7ce | 2026-03-31 | Warnings, Adverse reactions | 218535 ANDA218535 |
| carbidopa, levodopa and entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Alembic Pharmaceuticals Limited | 9ff83838-b7d0-4eec-98f2-fcc85789a189 | 2026-02-17 | Warnings, Adverse reactions | 218535 ANDA218535 |